John Grigg, Kathleen Digre, Paul Bernstein, Robyn Jamieson, Elisa Cornish, Vinit Mahajan, Sicong Geng, Carolyn Yanavich, Jieqing Fan, Danyang Liu, Zhengle Zhao, Shuai Zhang, Cong Xu, Tian Xu, Henri Lichenstein, Neil Solomons. "Preliminary immunologic and clinical Phase 1b study outcomes from patients with ROSAH syndrome treated with the first-in-class ALPK1 inhibitor DF-003 2307448." The Journal of Immunology, 2026. doi:10.1093/jimmun/vkag141.1377